CHENG MEI WEI
Known title: DirectorCIK: 0001191529
Associated companies
Transaction History
| LEA | ▲ Buy | Option Exercise | 236 | $0 | 2/20/2025 | View on chart |
| LEA | ▲ Buy | Option Exercise | 175 | $0 | 2/20/2025 | View on chart |
| LEA | ▲ Buy | Option Exercise | 284 | $0 | 2/20/2025 | View on chart |
| LEA | ▲ Buy | Option Exercise | 236 | $0 | 2/20/2024 | View on chart |
| LEA | ▲ Buy | Option Exercise | 175 | $0 | 2/20/2024 | View on chart |
| LEA | ▲ Buy | Option Exercise | 237 | $0 | 2/20/2023 | View on chart |
| LEA | ▲ Buy | Option Exercise | 175 | $0 | 2/20/2023 | View on chart |
| LEA | ▲ Buy | Option Exercise | 237 | $0 | 2/20/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
UBS and Goldman Sachs Lower Lear Price Targets
UBS and Goldman Sachs both maintained Neutral ratings on Lear but lowered their price targets to $132 and $124, respectively. This follows the stock trading near its support level, with the lower targets reflecting a more conservative outlook. The company remains in a list of attractive dividend stocks, maintaining a yield of 2.29%.
UBS and Goldman Sachs Lower Lear Price Targets. UBS and Goldman Sachs both maintained Neutral ratings on Lear but lowered their price targets to $132 and $124, respectively. This follows the stock trading near its support level, with the lower targets reflecting a more conservative outlook. The company remains in a list of attractive dividend stocks, maintaining a yield of 2.29%.